Screening of a human foetal brain genomic DNA library allowed us to isolate an EcoRI-EcoRI fragment containing 6 kb of the 5h-flanking region, the open reading frame and 4 kb of the 3h-flanking region of the α # C4 gene. Analysis of the sequenced region (4850 bp) revealed that the first 900 bp 5h to the start codon are very rich in GC (84 %), contain several Sp1-binding sites and lack a consensus TATA box. The 5h-and 3h-ends of the α # C4 transcript were determined by RNase-protection assays carried out with a series of antisense probes. The data obtained with cellular RNA from HepG2 cells demonstrated that transcription is initiated 891 bases upstream of the translation-start site and that the polyadenylation site is located 550 bases downstream of the stop codon. These results are consistent with the existence of a non-conventional TATA box (TTAGAAA)
INTRODUCTION
The α # -adrenergic receptors (ARs) constitute a class of seventransmembrane-domain receptors that mediate a number of cellular responses to catecholamines and that share the property of inhibiting adenylate cyclase using pertussis-toxin-sensitive Gproteins as signal transducers. Radioligand binding and molecular-biological approaches have now clearly established that these receptors exist as three pharmacological subtypes (α # A, α # B and α # C) [1] . Like most of the other members of the AR family, α # A-, α # B-and α # C-ARs are encoded by distinct intronless genes which are respectively designated α # C10, α # C2 and α # C4 in humans [2] [3] [4] . The physiological relevance of this diversity of receptors is not yet fully appreciated. The subtypes differ in their susceptibility to desensitization and down-regulation, indicating that they may be regulated differently after exposure to agonist [5, 6] . This conclusion, however, is not supported by results from experiments carried out on cells that naturally express the different α # -AR subtypes. The subtypes of α # -ARs also appear to diverge in their tissue distribution. However, large discrepancies have been observed according to the species examined or the method of analysis utilized [7, 8] , making it as yet difficult to obtain a clear idea of the exact pattern of α # -AR expression and to assign a given subtype to a specific function.
The α # C-AR can be pharmacologically distinguished from the α # A subtype by its sensitivity to prazosin and from the α # B subtype by its remarkably high affinity for [$H]MK912 [9] . On the basis of these properties, α # C-ARs were found expressed in human brain [10] and kidney [11] , but not in platelets, adipocytes and enterocytes which exclusively contain the α # A subtype [12] [13] [14] . In agreement with the pharmacological recognition of α # C-AR in human brain and kidney, these two tissues were demonstrated to contain large amounts of α # C4 mRNAs [8] . Substantial levels of α # C4 transcripts were also found in heart, Abbreviations used : ORF, open reading frame ; UTR, untranslated region ; FCS, foetal calf serum ; AR, adrenergic receptor ; RPA, RNase-protection assay. 1 To whom correspondence should be addressed.
and the presence of a unique polyadenylation signal (AATAAA). They also fit with the size of α # C4-RNA found by Northern-blot analysis (2n9 kb). The transcriptional activity of the α # C4 promoter region was investigated by transfecting several cell types with chimaeric constructs containing various fragments of the 5h-non-coding region and luciferase as a reporter gene. The activity of the construct containing the entire 5h-non-coding region appeared to depend on the host cell. Removal of the 5h-untranslated region resulted in loss of cell specificity and a concomitant increase in luciferase activity. Transfection of HepG2 and SK-N-MC cells with constructs deleted of additional 5h-flanking fragments permitted the definition of a minimal 200 bp promoter fragment containing the pseudo-TATA box and two putative SP1-binding sites. aorta and spleen [8] but the presence of α # C-AR in these latter tissues remains to be established. The reason why expression of the α # C4 gene is restricted to certain tissues is poorly understood, but it is likely that it lies in the characteristics of its promoter region. In contrast with α # C10, the 5h-flanking region of which has been sequenced and promoter elements studied in detail [15] [16] [17] [18] , the organization of the α # C4 gene is completely unknown. As the single exon of the α # C4 gene is only 1n38 kb in length [3] whereas α # C4 mRNA is about 2n9 kb in both heart and kidney [7] , one can simply assume that the α # C4 transcript contains rather long 5h-and\or 3h-untranslated regions (UTRs).
As a first approach to understanding the molecular mechanisms governing the expression and transcriptional regulation of the α # C-AR in human tissues, we have cloned and sequenced the 5h-and the 3h-flanking regions of the human α # C4 gene. The transcription-initiation and polyadenylation sites were determined by RNase-protection assays (RPAs) carried out on RNA prepared from the hepatoma cell line, HepG2. The functional activity of the promoter was analysed in different cell types transfected with chimaeric constructs containing luciferase as reporter gene.
MATERIALS AND METHODS

Screening of the human genomic library
The human foetal brain genomic DNA library in the cosmid SuperCos 1 vector (Stratagene, La Jolla, CA, U.S.A. ; catalogue no. 961200) was screened using the SacI-SmaI restriction fragment, corresponding to nucleotides 334\1016 of the human α # C4 coding region [3] . Titration, hybridization and washing were carried out as recommended by the manufacturer. After two rounds of screening, a cosmid containing an approx. 40 kb insert surrounding the α # C4 coding region was purified and charac-α 2 C4-adrenergic receptor gene promoter terized further by restriction enzyme digestion and Southern-blot analysis. This allowed us to clone in pBluescriptII KSj (pKS + ; Stratagene) an EcoRI-EcoRI fragment containing 6 kb of the 5h-flanking region, the open reading frame (ORF) and 4 kb of the 3h-flanking region of the α # C4 gene.
DNA sequencing and analysis
Restriction fragments of the EcoRI-EcoRI fragment were subcloned into pKS + . DNA was sequenced in both orientations using the dideoxy chain-termination method with the T7 Sequencing Kit from Pharmacia Biotech (Uppsala, Sweden) in combination with universal (T3, T7, M13-40) or specific primers. The sequences were analysed using the computer programs available at the w.w.w. server BCM Search Launcher of the Human Genome Center at Baylor College of Medicine (Houston, TX, U.S.A.).
RNA extraction, [ 32 P]riboprobe synthesis and RPA
Cellular RNA was isolated using the acid guanidinium thiocyanate\phenol\chloroform extraction method [19] . The integrity of the preparations was assessed by agarose-gel electrophoresis and RNA concentrations were measured by UV spectrophotometry. Antisense riboprobes for mapping of the transcriptionstart site were obtained by subcloning various fragments of the 5h-non-coding region of the α # C4 gene into pKS + . Five probes spanning 1367 bases 5h to the translation-start codon were used to determine the transcriptional start. Probe 1 corresponds to the P uII-NcoI fragment (nucleotides k205\j4), probe 2 to NotI-P uII fragment (nucleotides k620\k205), probe 3 to NcoI-SmaI fragment (nucleotides k1049\k538), probe 4 to NcoI-NotI fragment (nucleotides k1049\k793) and probe 5 to MaeIII-NotI fragment (nucleotides k1367\k793). Mapping of the 3h-end of the α # C4 transcript was performed using probe 6 which was prepared from the BamHI-BstXI fragment corresponding to nucleotides j1651\j2040. The plasmids were cleaved with the appropriate restriction enzyme, and antisense RNAs were synthesized in the presence of [$#P]UTP using the T3 or T7 RNA polymerase (Promega). RPA was performed as previously described but with slight modifications [20] . Lyophilized cellular RNA (100 µg) was placed in 30 µl of hybridization buffer [80 % (v\v) formamide, 0n4 M NaCl, 1 mM EDTA, 40 mM Pipes, pH 6n7] containing the [$#P]riboprobe. The samples were heated to 95 mC for 5 min and then immediately placed at 55 mC for 14 h. Non-hybridized probe was eliminated by the addition of 0n3 ml of a mixture of RNases (40 µg\ml RNase A and 2 µg\ml RNase T1) in TEN buffer (10 mM Tris\HCl, 5 mM EDTA, 300 mM NaCl, pH 7n5). After 2 h at 37 mC, digestion was stopped by addition of 5 µl of proteinase K (10 mg\ml), and the samples were further incubated for 15 min at 37 mC. Carrier tRNA (10 µg) and 0n3 ml of solution D [4 M guanidium isothiocyanate, 0n1 M 2-mercaptoethanol, 0n5 % (w\v) sarkosyl, 25 mM sodium citrate, pH 7n0] were added to each tube, and protected hybrids were precipitated with propan-2-ol. After a wash with 70 % (v\v) ethanol, RNA pellets were dissolved in 10 µl of sample buffer [97 % (v\v) formamide, 0n1 % (w\v) SDS, 10 mM Tris\HCl, pH 7n0] and loaded on to a 5 % (w\v) acrylamide\7 M urea gel. The gels were exposed for 48 h at k80 mC to X-ray film (Hyperfilm, Amersham, Bucks, U.K.) with an intensifying screen or analysed using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, U.S.A.).
Reporter gene constructs
The reporter gene constructs are numbered according to the translation-start site of α # C4 gene and were generated from the promoterless luciferase vector pGL3-Basic (Promega, Madison, WI, U.S.A.), as follows. First, the BamHI-NcoI fragment corresponding to the entire 5h-flanking region of α # C4 was introduced into the BglII and NcoI restriction sites of pGL3-Basic, resulting in a construct designated pGL3C4k2806\k1 where the ATG of luciferase is placed in the traductional context of the α # C4 gene. Secondly, the BamHI-PstI (k2806\k886) restriction fragment of the 5h-flanking region of the α # C4 gene was subcloned into the BamHI and PstI sites of pKS + . This fragment was then excised with either BamHI and HindIII or BamHI and EcoRV and inserted into the BglII-HindIII sites or the BglIII-SmaI sites of pGL3-Basic. This resulted in the creation of constructs containing the k2806\k886 fragment in sense or antisense orientation which were respectively named pGL3C4 k2806\k886 and pGL3C4k886\k2806.
pGL3C4k2806\k886 was then deleted using the SmaI site in the polylinker of pGL3 and the SspI (k2075), SmaI (k1799), P uII (k1699), StuI (k1633) or DraI (k1340) blunt sites of the α # C4 sequence to give the pGL3C4k2075\k886, pGL3C4 k1799\k886, pGL3C4k1699\k886, pGL3C4k1633\k886 and pGL3C4k1340\k886 respectively. Similarly, SacI deletion resulted in the generation of a shorter construct named pGL3C4 k1127\k886.
Deletion of pGL3C4k2806\k886 using the PstI sites located at positions k1494 and k886 allowed us to create the pGL3C4 k2806\k1494 construct. Insertion of the PstI-FspI fragment (k1494\k1105 of the α # C4 sequence) into the PstI and EcoRV sites of pGL3C4k2806\k1494 resulted in pGL3C4k2806\ k1105. Finally, pGL3C4k1043\k886 and pGL3C4k1127\ k961 were obtained by PCR using pGL3C4k1127\k886 as template. The k1043\k886 fragment was obtained using a sense primer 5h-CATGGTACCCCGAGCCGCCCGTGCTGC3h allowing the creation of KpnI site at position k1043 and an antisense primer located in the luciferase sequence. The k1127\ k961 fragment was obtained using a sense primer located in the pGL3 sequence and an antisense primer 5h-CTAAGACTGCAG-CCTCCTTCGCCTC-3h allowing the creation of a PstI site at position k961. The products from these amplifications were digested by KpnI and PstI and cloned in pGL3 digested with the same enzymes.
Cell culture, transfections and measurements of luciferase and β-galactosidase activities
HeLa (human cervix), HepG2 and SK-Hep (human hepatocarcinomas) were routinely subcultured in Dulbecco's modified Eagle's medium supplemented with 10 % foetal calf serum (FCS). SK-N-MC (human neuroblastoma) was grown in minimum essential medium containing 10 % FCS and 2 mM glutamine. All cell lines were transfected in 10 % FCS-supplemented Dulbecco's modified Eagle's medium using the calcium phosphate precipitation method [21] . Transfections were performed in 30 mmdiameter dishes using 4 µg of the different luciferase constructs and 1 µg of the pCMV-LacZ vector used as an internal control for transfection efficiency. Cells were collected 48 h after transfection and immediately disrupted in lysis buffer containing 100 mM potassium phosphate and 0n2 % (v\v) Triton X-100 (pH 7n5). Luciferase was measured in a 96-well plate luminometer (Luminoskan Labsystems, Labsystems Oy, Helsinki, Finland) using the luciferase reporter assay system from Promega. β-Galactosidase activity was determined using o-nitrophenyl β--galactopyranoside as substrate [22] .
RESULTS
Sequence analysis of the 5h-and 3h-flanking regions of the human α 2 C4 AR gene
The use of a 0n68 kb probe (corresponding to the SacI-SmaI fragment of the α # C4-coding region) to screen a human genomic library allowed us to isolate an 11 kb EcoRI-EcoRI fragment containing the α # C4 gene. The restriction map of this clone and the nucleotide sequence of the BamHI-BstXI fragment covering 2806 bp of the 5h-flanking region, the ORF and 658 bp of the 3h-flanking region of the α # C4 gene are presented in the Figure 1 . Analysis of the nucleotide composition of the 5h-flanking sequence indicates that the first 900 nt upstream of the translation-start site is composed of 84 % GjC residues (Figure 2 ). Neither TATA box nor CAAT box were found in this proximal region ; by contrast, numerous putative consensus binding sites for the transcription factor Sp1 (GC box) were identified. Several potential regulatory elements for controlling the transcriptional activity of many other genes were also detected. Notably a putative binding site for AP1 was detected at position k1237\ k1230. The consensus sequence for transcription factors of the c-Myc family was found at position k1520\k1507. Two halfsites for peroxisome-proliferation-activated receptor were found at positions k1808\k1803 (TGACCT) and k2209\k2204 (AGGTCA). Analysis of the whole 5h-region using transcription start site Ghosh (TSSG) indicated the existence of two possible promoters with transcription-initiation sites predicted at position k490 and k910 relative to the start codon. In contrast with that at k490, the initiation-start site predicted at k910 included a pseudo-TATA box (TTAGAAA) at position k954\k949.
Figure 2 Analysis of the GjC content of the human α 2 C4 gene
Examination of the 3h-flanking region revealed the existence of a 21-base direct repeat (GGGGAGCTTTCCCAGAGACCC) located 70 bases downstream of the stop codon. It also indicated the presence of a sequence for RNA destabilization (ATTTA) at position j1871\j1875 and of a single canonical polyadenylation signal (AATAAA) at position j1921\j1926. The search for sequence homology by performing a BLAST [21] against the 661-base fragment of the 3h-non-coding region (TGA-BstXI fragment) permitted the identification of a previously partially sequenced human placental cDNA clone (Washington University-Merck EST project, clone no. T40595) which displays an almost perfect homology with the α # C4 (one mismatch over 344 bases). This clone ends 14 bases downstream of the polyadenylation signal, indicating that the polyadenylation site may be located at position j1940 of the α # C4 gene sequence.
Identification of the 5h-and 3h-ends of the α 2 C4 mRNA
To locate the promoter region, we first identified the 5h-end of α # C4 mRNA. A recent study from our group demonstrated that the human hepatocarcinoma cell line HepG2 expresses α # -ARs of the α # C subtype and contains large amounts of α # C4 transcripts [23] ; RNAs prepared from this cell line were thus used to map the α # C4 mRNA transcriptional-start site by RPA. The size and location of the five antisense riboprobes used for this purpose are shown in Figure 3 . Probes 1 and 2, which together cover 620 bases upstream of ATG, were fully protected by cellular RNA from HepG2. In contrast, probe 3 was only partially protected on about 350 bases indicating that the transcriptional-start site was located approx. 900 bases 5h to the codon start site. Probes 4 and 5 were thus used to identify the cap site more precisely. As expected from the results obtained with probe 3, probes 4 and 5 were partially protected over a region of identical size. The determination of the length of the protected region using 54-, 103-and 148-base labelled riboprobes allowed us to calculate that both probe 4 and 5 were protected on 98p2 nt. Similar results were obtained using RNA prepared from human kidney (not shown). Thus, according to these data, the transcriptionalstart site of the α # C4 gene is located 891p2 bases upstream of the start codon. This conclusion is in good agreement with the computer prediction of a putative non-canonical TATA box (TTAGAAA) at position k954\k949. However, attempts to identify more precisely the cap site by means of primer extension were unsuccessful. This failure was primarily due to the impossibility of designing a suitable primer in this region and to the inherent difficulty in reverse-transcribing such GC-rich mRNA.
The functionality and unity of the polyadenylation signal located at position j1921\j1926 of the α # C4 sequence was also confirmed by RPA. As shown in Figure 4 , probe 6, which corresponds to nucleotides j1650\j2034, was protected by HepG2 RNA on about 290 bases indicating the existence of a single polyadenylation site located 550 bases downstream of the stop codon. Taken together, the results from RPA demonstrate that α # C4 mRNA is about 2840 bases in length.
Analysis of promoter activity of the α 2 C4 5h-flanking region in various cell lines
We next sought to characterize the promoter activity of the α # C4 5h-flanking region. For this purpose we first transfected several cell lines with constructs containing either the complete 5h-flanking region (pGL3C4k2806\k1) or a fragment terminating five bases downstream of the transcription-start site detected by RPA (k2806\k886). This latter fragment was tested in sense (pGL3C4k2806\k886) and reverse orientation (pGL3C4 α 2 C4-adrenergic receptor gene promoter
Figure 3 Identification of the transcription-initiation site of the human α 2 C4 gene
The 5h-end of the α 2 C4 mRNA was mapped by RPA carried out on 100 µg of HepG2 cellular RNA. The five probes used cover 1367 bases 5h to the codon start. The sites used for their construction were as follows : Pvu II and Nco I for probe 1 ; Not I and Pvu II for probe 2 ; Nco I and Sma I for probe 3 ; Nco I and Not I for probe 4 ; Mae III and Not I for probe 5. 0 n 74p0n22 0n37p0n31 3n33p0n78* 2n52p0n13* pGL3C4k2806/k886 2n38p0n22* 7n60p4n15* 14n3p1n62* 6n20p1n03* pGL3C4k886/k2806 0n58p0n26 0n19p0n05 1n44p0n44 0n74p0n13 pGL3-SV40 12n6p1n7* 29n7p5n4* 20n7p3n8* 28n4p3n3*
we verified that all lines tested could be efficiently transfected using pGL3-SV40 as a positive control. The results of this study are summarized in Table 1 . It appears that the transfection of pGL3C4k2801\k1 in cell lines that do not express the α # C4 gene (SK-Hep and HeLa) led to a normalized luciferase activity similar to or less than that found with the promotorless vector, pGL3-Basic. In contrast, this construct is able to promote a
Figure 5 Transient expression of α 2 C4 promoter-luciferase constructs in HepG2 and SK-N-MC cells
HepG2 cells () and SK-N-MC cells ( ) were transfected as described in the Materials and methods section using the calcium phosphate precipitation method. Deletions were numbered according to their location relative to the start codon. Luciferase activity was measured as relative light units. The activity of the different constructs was adjusted for efficiency of transfection standardized by co-transfection of pCMV-LacZ. Results are expressed as fold increase in luciferase activity of the promoterless luciferase vector pGL3-Basic. Values are meanspS.E.M. from six independent experiments. slight but significant luciferase activity in the two human cell lines that endogenously express α # C-ARs (HepG2 and SK-N-MC) [23] . This divergence is not due to difference in transfection efficiency since pGL3-SV40 is strongly active in all cells tested. The results obtained with pGL3C4k2806\k886 demonstrate that the removal of the GC-rich 5h-UTR not only provoked a significant increase in luciferase activity in HepG2 and SK-N-MC cells but also resulted in expression in all cell types, suggesting that the k886\j1 region harbours sequences responsible for cell-specific expression of the α # C4 gene. Finally, whatever the cell line considered, the construct containing the k2806\k886 fragment in reverse orientation (pGL3C4k886\k2806) did not promote activity, indicating that this fragment behaves as a true promoter with orientation-dependent activity.
Study of the α 2 C4 promoter region in HepG2 and SK-N-MC cells
The promoter region of the α # C4 gene was further studied by transfecting HepG2 and SK-N-MC cells with the series of deleted constructs generated as described in the Material and methods section. The results from these experiments are presented in Figure 5 . Transfection of HepG2 cells indicated that the progressive removal of fragments stretching between nucleotides k2806 and k1633 resulted in a gradual increase in luciferase activity. In this cell line, the maximum activity was obtained with pGL3C4k1633\k886 and reached 17-fold greater activity than the promoterless construct pGL3-Basic. Further deletion in the 5h-end resulted in a decrease in activity ; however, the 240 bp fragment (k1127\k886) which contained the putative pseudo-TATA box and two Sp1-binding sites was still able to promote luciferase activity at a level similar to that observed with the fulllength promoter construct. In agreement with a critical role for this short region, deletion of this fragment resulted in a total loss of promoter activity, HepG2 cells transfected with either pGL3C4k2806\k1494 or pGL3C4k2806\k1105 exhibiting a luciferase activity similar to or even lower than pGL3-Basic. Otherwise, the construct pGL3C4k1127\k961, from which the pseudo-TATA box was deleted, exhibited 3-fold lower activity than pGL3C4k1127\k886, suggesting that the TTAGAAA sequence functions as a TATA box. The results obtained with SK-N-MC cells differ somewhat from those with HepG2 cells. The highest level of luciferase activity in the neuroblastoma cell line was achieved by the pGL3C4k2806\k886 and pGL3C4 k2075\k886 constructs, which yielded a 14-fold greater activity than the promoterless vector pGL3-Basic. The removal of the k2075\k1799 fragment resulted in a 50 % attenuation of luciferase expression. Further removal of fragments between nucleotides k1799 and k1633 did not result in any significant change. As previously noted for HepG2 cells, deletion of fragment k1633\k1340 provoked a further attenuation of activity. Moreover, pGL3C4k2806\1494 and pGL3C4k2806\k1105 were also devoid of activity in SK-N-MC cells. α 2 C4-adrenergic receptor gene promoter
DISCUSSION
With the exception of the α # C10 gene, the promoter of which has been the subject of detailed study [15] [16] [17] [18] , the upstream regions of the genes encoding other human α # -ARs (namely α # C2 and α # C4) remain completely unknown. The present work was thus carried out as an initial approach to the characterization of the organization of the α # C4 gene and to define the elements accounting for the relatively restricted expression of the α # C-AR subtype in human tissues.
Screening of a human genomic library allowed us to isolate an EcoRI-EcoRI clone, the restriction map and Southern-blot analysis of which indicated that it contained the α # C4 ORF surrounded by 6 kb of 5h-flanking region and 4 kb of 3h-flanking region. Analysis of the sequence of the 5h-region suggested that the α # C4 gene exhibits many of the features of a housekeeping gene. It contains neither a conventional TATA box nor a CAAT box, but has a very high GjC content and multiple Sp1-binding sites. In contrast with what one would have expected for a TATA-less and GC-rich gene, RPA carried out on RNA prepared from HepG2 cells showed that transcription of the α # C4 gene is initiated from a single site 891 bases upstream of the translationstart site. Using the same method, the polyadenylation site was found to be located 550 bases downstream of the stop codon. Given these results, the size of α # C4 mRNA is 2840 nt. Adding on the poly(A) tail, the calculated size is in good agreement with the size of the α # C-AR mRNA (2n9 kb) found by Northern-blot analysis of polyadenylated RNAs from human kidney and heart [7] . The length of the 5h-leader region of α # C4 mRNA also matches well with the length of the 5h-end of a previously isolated rat brain cDNA (pA2d) encoding the rodent α # C-AR [24] . It is moreover in agreement with data obtained in gene-transfer experiments demonstrating that DNA elements that are indispensable for conveying significant levels of expression lie within the k1127\k886 fragment. This short fragment notably contains the sequence TTAGAAA, which may function as a TATA-like box. Such a role remains to be established, but the sharp diminution in promoter activity observed in the construct deleted of a 71-base segment containing this region suggests that the TTAGAAA motif may effectively serve to position the transcription-initiation complex as does a conventional TATAbox.
The transfection experiments indicate that the activity of the construct containing the entire 5h-flanking region is, at least to some extent, dependent on the host cell. They also suggest that removal of the 5h-UTR resulted in loss of cell specificity and a concomitant increase in luciferase activity. The mechanism by which the 5h-UTR of the α # C4 gene affects expression was not investigated in the present work. However, the 5h-leader region of α # C4 mRNA exhibits at least two features that may participate in the attenuation of the translation of the major ORF [25] . First, the 5h-end of the mRNA is extremely rich in GjC and may form strong secondary structures. Secondly, like other members of the AR family [26] , the 5h-leader region of the α # C4 gene harbours a 43-codon micro-ORF (nucleotides k447 to k319) which may interfere with translation.
The transfections with the series of 5h-deleted constructs revealed some important differences in transcriptional regulation between HepG2 and SK-N-MC, cells, thus suggesting the possible presence of a repressor in one cell line but not in the other. In both models, however, deletion of the k1633\k1340 fragment provoked a large attenuation of luciferase activity. Interestingly, this region contains a putative binding site for transcription factors of the basic helix-loop-helix protein family. This group includes c-Myc, related proteins such as Max and Mad, as well as the upstream stimulatory factor. Although ubiquitously expressed, these factors have been frequently recognized to be involved in the tissue-specific control of gene expression [27] .
While the present study was in progress, Saulnier-Blache et al. [28] published a description of the promoter region of the RG10 gene which is the rodent homologue of the α # C4 gene. Alignment of the two sequences revealed a high degree of homology. More precisely, the first 900 bases 5h to the methionine start of RG10 displayed 80 % homology with that of α # C4. This region was similarly rich in GC and presented several putative Sp1-binding sites. Moreover, the pseudo-TATA box (TTAGAAA) and the AP1-binding site, respectively found at positions k954\k949 and k1229\k1223 of the α # C4 gene, were also encountered at positions k926\k932 and k1184\k1178 of the RG10 gene sequence. Although they are highly conserved, the promoter regions of the rat and human genes appear to function very differently. Indeed, according to RPA with rat brain RNA and transfection experiments in NG-108-15 cells, RG10 gene transcription is initiated at multiple sites through the promoter activity of a 96 nt GC-rich region located 700 bases upstream of the methionine initiation site. This small fragment is moreover sufficient to specifically direct expression of rat α # C-AR in cells of neuronal origin. The reasons for the functional differences between human and rat genes have been ignored, but they may explain why RG10 mRNA is primarily expressed in rat central nervous system, whereas α # C4 mRNA distribution in human extends to peripheral tissues [7, 8, [29] [30] [31] [32] . The discrepancies between the results obtained in human and rat may arise from the fact that RG10 and α # C4 were studied in cells of different origin (namely NG108-15 and HepG2). Thus, even if the transfection experiments in SK-N-MC do not favour such a possibility, the existence of a second promoter identical with that described in rat and preferentially active in human neuronal tissue cannot be ruled out. Finally, as suggested by the length of the 5h-end of the rat cDNA isolated by Voigt et al. [24] , it is possible that the RG10 gene also contains two promoter regions. Multiple alternative promoters is a frequently used mechanism to create diversity and flexibility in the regulation of gene expression [33] . Other examples of ARs with multiple promoters have been described. The gene encoding the α " b subtype was shown to have three promoters, two of which are TATA-less and GC-rich [34] .
In summary, the present work provides for the first time precise indications about the organization of the human α # C4 gene. It demonstrates that transcription is initiated 891 bases upstream of ATG through the activity of a minimal promoter region that lacks a CCAAT box but contains a pseudo-TATA box and other proximal nuclear-factor-binding sites including two GC boxes. Confirmation of the precise roles of these elements awaits definitive demonstration by footprint analysis. Our transfection experiments also indicate divergent roles for regions 5h of the minimal promoter in regulating transcription in HepG2 and SK-N-MC cells. They also suggest a role for the downstream region in cell-specific expression of the α # C4 gene. The issue of whether the 5h-UTR is indeed important for tissue-specific expression of α # C-AR in i o also requires further investigation.
